127 related articles for article (PubMed ID: 38894145)
1. Developing a Portable Autofluorescence Detection System and Its Application in Biological Samples.
Zhou J; Li Y; Zhang J; Cai F
Sensors (Basel); 2024 May; 24(11):. PubMed ID: 38894145
[TBL] [Abstract][Full Text] [Related]
2. Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus.
Genevieve M; Vivot A; Gonzalez C; Raffaitin C; Barberger-Gateau P; Gin H; Rigalleau V
Diabetes Metab; 2013 Sep; 39(4):349-54. PubMed ID: 23643347
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of autofluorescent property of hemoglobin-advanced glycation end product as a long-term glycemic index of diabetes.
Gopalkrishnapillai B; Nadanathangam V; Karmakar N; Anand S; Misra A
Diabetes; 2003 Apr; 52(4):1041-6. PubMed ID: 12663478
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products are associated with arterial stiffness in type 1 diabetes.
Llauradó G; Ceperuelo-Mallafré V; Vilardell C; Simó R; Gil P; Cano A; Vendrell J; González-Clemente JM
J Endocrinol; 2014 Jun; 221(3):405-13. PubMed ID: 24681829
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
[TBL] [Abstract][Full Text] [Related]
6. Simple noninvasive measurement of skin autofluorescence.
Meerwaldt R; Links T; Graaff R; Thorpe SR; Baynes JW; Hartog J; Gans R; Smit A
Ann N Y Acad Sci; 2005 Jun; 1043():290-8. PubMed ID: 16037251
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products as predictors of renal function in youth with type 1 diabetes.
Forbes JM; Le Bagge S; Righi S; Fotheringham AK; Gallo LA; McCarthy DA; Leung S; Baskerville T; Nisbett J; Morton A; Teasdale S; D'Silva N; Barrett H; Jones T; Couper J; Donaghue K; Isbel N; Johnson DW; Donnellan L; Deo P; Akison LK; Moritz KM; O'Moore-Sullivan T
Sci Rep; 2021 May; 11(1):9422. PubMed ID: 33941808
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of skin autofluorescence as a surrogate of advanced glycation end products accumulation in children and adolescents with normal haemoglobin A1c values.
Jankowska M; Bobeff K; Baranowska-Jaźwiecka A; Mianowska M; Lubnauer A; Michalak A; Młynarski W; Szadkowska A; Mianowska B
Pediatr Endocrinol Diabetes Metab; 2020; 26(1):1-9. PubMed ID: 32418416
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction.
Januszewski AS; Sachithanandan N; Karschimkus C; O'Neal DN; Yeung CK; Alkatib N; Jenkins AJ
Diabet Med; 2012 Jun; 29(6):726-33. PubMed ID: 22211881
[TBL] [Abstract][Full Text] [Related]
11. Clinical and technical factors associated with skin intrinsic fluorescence in subjects with type 1 diabetes from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
Cleary PA; Braffett BH; Orchard T; Lyons TJ; Maynard J; Cowie C; Gubitosi-Klug RA; Way J; Anderson K; Barnie A; Villavicencio S;
Diabetes Technol Ther; 2013 Jun; 15(6):466-74. PubMed ID: 23882708
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in hemodialyzed patients with diabetes mellitus correlate with leptin and leptin/body fat ratio.
Kalousová M; Sulková S; Zima T; Deppisch R; Beck W; Bednárová sV; Fortová M; Tesar V
Ren Fail; 2003 Mar; 25(2):277-86. PubMed ID: 12739834
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation Endproducts as Biomarkers for Risk of Diabetes and Cardiovascular Diseases by Skin Autofluorescence: A Noninvasive Optical Screening.
Paolillo FR; Mattos VS; Borghi-Silva A; Bagnato VS; de Castro Neto JC
Photobiomodul Photomed Laser Surg; 2019 Mar; 37(3):168-174. PubMed ID: 31050947
[No Abstract] [Full Text] [Related]
14. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
15. Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes.
Kouidrat Y; Zaitouni A; Amad A; Diouf M; Desailloud R; Loas G; Lalau JD
J Diabetes Complications; 2017 Jan; 31(1):108-113. PubMed ID: 27847146
[TBL] [Abstract][Full Text] [Related]
16. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue.
Yue X; Hu H; Koetsier M; Graaff R; Han C
Diabet Med; 2011 Jul; 28(7):818-23. PubMed ID: 21204956
[TBL] [Abstract][Full Text] [Related]
17. Assessment of advanced glycated end product accumulation in skin using auto fluorescence multispectral imaging.
Larsson M; Favilla R; Strömberg T
Comput Biol Med; 2017 Jun; 85():106-111. PubMed ID: 27106500
[TBL] [Abstract][Full Text] [Related]
18. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
19. Advanced glycation end products, measured in skin, vs. HbA1c in children with type 1 diabetes mellitus.
Banser A; Naafs JC; Hoorweg-Nijman JJ; van de Garde EM; van der Vorst MM
Pediatr Diabetes; 2016 Sep; 17(6):426-32. PubMed ID: 26332801
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive optical screening for diabetes.
Ediger MN; Olson BP; Maynard JD
J Diabetes Sci Technol; 2009 Jul; 3(4):776-80. PubMed ID: 20144328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
